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In C. elegans, removing the germ cells extends
life span by triggering the nuclear localization
and activation of the DAF-16/FOXO transcrip-
tion factor in the intestine. In this study, we
identify and analyze genes required for germ-
line removal to extend life span. We find that
the reproductive system communicates with
the intestine through lipophilic-hormone signal-
ing and that a gene called kri-1 is likely to act in
the intestine to promote DAF-16 nuclear locali-
zation in response to this signal. This lipophilic-
signaling pathway and kri-1 are not required for
DAF-16’s nuclear localization and life-span ex-
tension in animals with decreased insulin/IGF-1
signaling. Thus, this pathway specifically en-
ables the integration of cues from the repro-
ductive system with central DAF-16-activation
pathways to influence the aging of the animal.
INTRODUCTION
Although studied extensively by evolutionary biologists,
the interplay between an animal’s reproductive status
and its rate of aging is only beginning to be explored at
the molecular level. Cues from the reproductive system
modulate the rate of aging of C. elegans, an organism
well suited for molecular studies of aging because of its ge-
netic tractability and short life span. When the germline of
C. elegans is removed using a laser microbeam or with mu-
tations that block germ-cell proliferation, adult animals live
up to 60% longer than intact controls. However, when the
entire somatic gonad is removed, the worm has a normal
life span. Thus, sterility alone does not lengthen life. These
and other findings suggest that C. elegans’ life span is
influenced by counterbalancing cues from the reproduc-
tive system: signals from proliferating germ cells reduce
longevity, while signals from the somatic gonad promote
a longer life (Arantes-Oliveira et al., 2002; Hsin and Ken-
yon, 1999).At least three genes are required for germline removal to
extend C. elegans life span: daf-16, daf-12 (Hsin and Ken-
yon, 1999), and daf-9 (Gerisch et al., 2001). daf-16 en-
codes a FOXO-family transcription factor (Lin et al.,
1997; Ogg et al., 1997) studied extensively as the major
downstream effector of the insulin/IGF-1-pathway (re-
viewed in Kenyon, 2005; Tatar et al., 2003). Under normal
conditions, DAF-2, the C. elegans insulin/IGF-1 receptor,
activates a conserved PI 3-kinase/PDK/AKT signaling cas-
cade that phosphorylates DAF-16, thereby preventing its
nuclear localization. When insulin/IGF-1 signaling is in-
hibited, DAF-16 accumulates in the nucleus and regulates
downstream genes that extend life span. Removing the
germline of daf-2 mutants causes a further doubling of
life span (Hsin and Kenyon, 1999). Signals from the germ-
line could therefore act in parallel to the DAF-2 pathway to
regulate DAF-16, though this need not be the case. DAF-
12, a nuclear hormone receptor related to the vitamin D
and pregnane X receptors, and DAF-9, a cytochrome
P450 postulated to make or modify a lipophilic ligand for
DAF-12, are also required for germline ablation to extend
life span (Antebi et al., 2000; Gerisch et al., 2001; Hsin
and Kenyon, 1999). Therefore, the germline attenuates
longevity through the downregulation of lipophilic-hormone
signaling and changes in transcription. It is not known,
however, how these three genes interact with one another
or what other genes participate in this pathway.
Signaling between the reproductive system and the intes-
tine is required for germline removal to extend life span. In
germline-defective animals, DAF-16, which is present
throughout the animal, enters the nuclei of intestinal cells
(Lin et al., 2001). This localization is likely to be important,
since germline-defective animals with daf-16 expressed
solely in the intestine live as long as germline-defective an-
imals that have a wild-type daf-16 gene (Libina et al., 2003).
The intestine—which, as the entire endoderm of the animal,
also serves as its adipose tissue—is therefore a central site
of action for the interpretation and execution of information
coming from the reproductive system. It is not known how
the germline transmits signals to the intestine to influence
the activity or subcellular localization of DAF-16.
To better understand how the reproductive system
affects aging, we conducted a screen for new genesCell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1055
required for the loss of germ cells to lengthen life span. We
find that a gene called kri-1, which encodes an intestinal
ankyrin-repeat protein orthologous to the human disease
gene KRIT1/CCM1 (Laberge-le Couteulx et al., 1999;
Sahoo et al., 1999), is required for DAF-16 nuclear localiza-
tion and longevity in animals lacking a germline. In addition,
we find that daf-12 and daf-9 are required for DAF-16
nuclear localization in germline-deficient animals, indicat-
ing that lipophilic-hormone signaling is used to transmit
information from the reproductive system to DAF-16 in
the intestine. KRI-1 and DAF-9 may act primarily to pro-
mote DAF-16 nuclear localization, whereas DAF-12 has
additional functions in this pathway. This pathway is not re-
quired for the nuclear localization and function of DAF-16
that occur in response to DAF-2-pathway inhibition.
Thus, these genes play a specific role in transmitting sig-
nals that reflect the status of the germline to the animal’s
life-span control machinery.
RESULTS
kri-1 Is Required for the Longevity of Animals
Lacking a Germline
To better understand how the loss of germ cells extends
life span, we screened for genes whose activities are
required for the longevity of animals lacking a germline.
The screen was conducted using a mutant, glp-1(e2141ts),
which is sterile at the nonpermissive temperature due to
a failure of germline proliferation (Priess et al., 1987).
When sterile, glp-1(e2141ts) animals are long lived, and
their longevity is dependent on the presence of the so-
matic gonad, as well as on daf-16, daf-12, and daf-9 (Fig-
ure 1; Arantes-Oliveira et al., 2002; J.R.B., M. Hansen, F.
Broue, and C.K., unpublished data). We screened a chro-
mosome I RNAi feeding library (Fraser et al., 2000) to iden-
tify RNAi clones that suppressed the enhanced longevity
of sterile glp-1 animals. Suppressors were identified on
the day on which roughly 50% of glp-1 animals grown on
control bacteria were still alive, whereas almost all animals
grown on bacteria expressing daf-16 or daf-12 dsRNA
were dead (see Experimental Procedures). Of the 2103
clones assayed, 44 clones reproducibly suppressed glp-1
longevity yet had no reported or observed lethal or sick
phenotypes (data not shown). Two independent RNAi
clones of daf-16/FOXO were identified in the screen, vali-
dating our approach.
Because inactivation of many genes can compromise
an animal’s health, we focused on RNAi clones that, like
daf-16 RNAi, significantly shortened glp-1 longevity but
had a much smaller effect on wild-type. Among other
genes (unpublished data), we found that RNAi of a gene
named kri-1 (cosmid number ZK265.1), which encodes
a conserved protein with ankyrin repeats, shortened
glp-1 longevity dramatically but had no effect on wild-
type life span (Figures 1A and 1B; Table 1). Similar effects
were seen when glp-1 animals were subjected to daf-16
or daf-12 RNAi, consistent with phenotypes observed in
mutant studies (Table 1, (Hsin and Kenyon, 1999)). Overall,1056 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Incanimals fed the kri-1 RNAi bacterial clone appeared nor-
mal, although somewhat thinner and paler than control an-
imals (data not shown). The animals appeared to repro-
duce normally, and they had normal rates of growth to
adulthood and of pumping (feeding) (data not shown).
To learn how complete loss of kri-1 function influences
longevity, we obtained a kri-1 deletion mutant (allele
ok1251) from the C. elegans Gene Knockout Consortium
and constructed a kri-1(ok1251);glp-1(e2141ts) double
mutant. The kri-1 deletion allele completely suppressed
glp-1 longevity, shortening mean life span by up to 45%
(Figure 1C; Table 1). These animals had a mean life span
similar to that of the short-lived daf-16;glp-1 control strain
(Figure 1C; Table 1). DNA sequencing revealed that
ok1251 is a deletion and complex rearrangement in the
kri-1 coding sequence that creates an early stop codon
upstream of the ankyrin repeats (see Experimental Proce-
dures). kri-1(ok1251) mutant animals were slightly smaller
and paler than normal, and many displayed a bagging (ma-
tricide due to internal hatching of progeny) phenotype not
seen in RNAi-treated animals (data not shown). Our RNAi
conditions may therefore represent a partial knockdown
of kri-1 gene function.
kri-1 Acts Specifically in the Reproductive
Signaling Pathway
Given the profound impact that kri-1 mutation has on the
life spans ofglp-1 animals, we wondered whether reducing
kri-1 function would also shorten the long life spans of
insulin/IGF-1-pathway mutants. Mutations in the insulin/
IGF-1 receptor ortholog daf-2 double the life span of
C. elegans, and this longevity is dependent on daf-16/
FOXO (Kenyon et al., 1993). We found that, unlike daf-16
RNAi, kri-1 RNAi did not shorten the life span of daf-
2(e1370) mutants; instead, surprisingly, it increased life
span by up to 23% (Figure 1D; Table 1). The effect on
daf-2 mutant life span was allele specific, as kri-1 RNAi
had either no effect or a slight life-span-shortening effect
on animals carrying the weaker allele, daf-2(e1368) (Fig-
ure 1E; Table 1). Since kri-1 RNAi completely suppressed
the extended life span of glp-1 mutants, but not wild-
type or daf-2 mutants, kri-1(+)’s role in life-span extension
appears to be specific to the reproductive pathway.
In addition to affecting life span, daf-2 also regulates en-
try into a state of diapause called dauer. NormalC. elegans
larvae become dauers under adverse conditions, whereas
strong daf-2 mutants become dauers constitutively (Rid-
dle and Albert, 1997). Loss of the germline does not affect
dauer formation (Hansen et al., 2005). Dauer formation re-
quires daf-16 and daf-12, so we wondered whether it re-
quires kri-1 as well. We found that reducing kri-1 function
did not prevent dauer formation in daf-2(e1368) mutants,
though a small fraction of the animals (10%) arrested de-
velopment as young (L1/L2) larvae (see Table S4 in the
Supplemental Data available with this article online). This
finding further uncouples kri-1 activity from the DAF-2
pathway, and it also suggests that not all daf-12-depen-
dent processes require kri-1..
Figure 1. Effect of kri-1 RNAi or Mutation on the Longevity of glp-1, N2, and daf-2 Animals
kri-1 RNAi (A) or mutation (C) suppresses the longevity of glp-1 germline-deficient animals, whereas kri-1 RNAi does not affect N2 (wild-type) life span
(B). kri-1 RNAi can enhance the longevity of daf-2(e1370) mutants (D) but has no or mild effects on daf-2(e1368) longevity ([E]; see Table 1). Life-span
assays were performed as described (see Experimental Procedures), and all life-span curves presented in this and subsequent figures are the result of
one representative trial. (E), an exception, represents the sum of animals in multiple experiments since the log-rank (Mantel-Cox) statistics confirmed
our observation that animals in these experiments behaved similarly. Mean life-span data, allele names, and additional trials are listed in Table 1,
where each experiment presented in Figure 1 is indicated by b.kri-1 Is Expressed in the Intestine
To learn where KRI-1 might function, we fused gfp to the 50
end of the kri-1 coding sequence and expressed the fusion
under the control of the kri-1 promoter (see Experimental
Procedures). In wild-type animals, we observed expres-
sion of kri-1::gfp in the intestine and pharynx throughout
all stages of postembryonic development and adulthood
(Figures 2A–2C and data not shown). In most cells, KRI-
1::GFP appeared diffuse. However, the fusion protein dis-
played subcellular enrichment at the apical and apicolat-
eral surfaces of many intestinal and pharynx cells
(Figure 2B). In addition, some animals displayed nuclearenrichment of KRI-1 in intestinal cells (Figure 2C). We
asked whether germline removal might alter this localiza-
tion pattern and found that it did not (data not shown).
To ask whether the fusion protein was functional, we in-
troduced it into kri-1;glp-1mutant animals and determined
their life spans. We found using independent transgenic
lines that the kri-1::gfp fusion increased the shortened life
span of kri-1;glp-1 animals, although the animals did not
live as long as kri-1(+);glp-1 animals (Figure 2D; Table 1).
This result indicates that kri-1 expression in the intes-
tine and/or pharynx is functionally important for life-span
regulation.Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1057
Table 1. Effect of kri-1 Loss or Restoration of Function on glp-1, N2, and daf-2 Longevity
Genotype
Background
RNAi
Treatment
(if Applicable) Experiment
Mean LS ± SEM
(Days)
Events/
Obs (Trials)a
% of
Control
p Value
versus
Control
glp-1(e2141ts) control 1b 24.6 ± 0.7 128/170 (1)
kri-1 17.6 ± 0.4 43/60 (1) 72 <0.0001
daf-16 14.7 ± 0.3 116/158 (1) 60 <0.0001
daf-12 17.7 ± 0.4 133/160 (1) 72 <0.0001
control 2 19.8 ± 1.2 78/84 (1)
kri-1 15.1 ± 0.5 71/72 (1) 76 0.0002
daf-16 12.9 ± 0.4 41/72 (1) 65 <0.0001
daf-12 15.7 ± 0.6 62/72 (1) 79 0.0018
N2 (wild-type) control 1 19.7 ± 0.7 56/145 (1)
kri-1 19.8 ± 0.7 38/65 (1) 101 0.86
daf-16 15.9 ± 0.6 34/65 (1) 81 0.0002
daf-12 17.2 ± 0.7 41/65 (1) 87 0.015
control 2b 18.2 ± 0.5 57/80 (1)
kri-1 18.6 ± 0.5 71/80 (1) 102 0.37
daf-16 15.2 ± 0.4 50/80 (1) 84 <0.0001
daf-12 16.9 ± 0.6 63/80 (1) 93 0.18
glp-1(e2141ts) 1b 30.9 ± 1.5 59/72 (1)
2 27.7 ± 1.2 60/75 (1)
kri-1(ok1251);glp-1(e2141ts) 1 17.0 ± 0.4 58/70 (1) 55 <0.0001
2 17.6 ± 0.7 57/60 (1) 64 <0.0001
daf-16(mu86);glp-1(e2141ts) 1 15.0 ± 0.6 54/60 (1) 49 <0.0001
daf-2(e1370) control 1b 45.4 ± 2.4 60/80 (1)
daf-16 22.2 ± 0.7 59/80 (1) 49 <0.0001
kri-1 54.8 ± 2.3 58/80 (1) 123 0.017
control 2 43.9 ± 1.7 73/100 (1)
daf-16 21.7 ± 0.6 43/80 (1) 49 <0.0001
kri-1 48.0 ± 2.3 53/80 (1) 109 0.18
rrf-3(pk1426);daf-2(e1370) control 46.9 ± 1.5 59/94 (1)
daf-16 20.8 ± 0.9 26/70 (1) 44 <0.0001
kri-1 52.5 ± 2.0 56/82 (1) 112 0.014
daf-2(e1368) control b 30.2 ± 0.6 122/225 (2)
daf-16 20.2 ± 0.4 108/160 (2) 67 <0.0001
kri-1 30.3 ± 0.6 98/145 (2) 100 0.89
rrf-3(pk1426);daf-2(e1368) control 30.3 ± 1.6 50/70 (1)
daf-16 19.5 ± 0.9 45/70 (1) 64 <0.0001
kri-1 25.1 ± 1.0 59/70 (1) 83 0.0007
glp-1(e2141ts) 26.6 ± 1.4 66/84 (1)
kri-1(ok1251);glp-1(e2141);
muEx353 [Pkri-1::gfp::kri-1]
1c 20.2 ± 0.7 72/84 (1) 0.0003d
2 19.5 ± 0.5 80/96 (1) <0.0001d1058 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc.
Table 1. Continued
Genotype
Background
RNAi
Treatment
(if Applicable) Experiment
Mean LS ± SEM
(Days)
Events/
Obs (Trials)a
% of
Control
p Value
versus
Control
kri-1(ok1251);glp-1(e2141)
nontransgenic siblings
1 16.8 ± 0.6 62/72 (1)
2 16.0 ± 0.4 78/84 (1)
kri-1(ok1251);glp-1(e2141);
muEx354 [Pkri-1::gfp::kri-1]
1 18.9 ± 0.9 71/86 (1) 0.12d
2c 21.3 ± 0.7 77/96 (1) <0.0001d
kri-1(ok1251);glp-1(e2141)
nontransgenic siblings
1 17.2 ± 0.6 62/72 (1)
2 16.1 ± 0.4 70/84 (1)
Where noted, animals were exposed to dsRNA of the gene listed in the ‘‘RNAi Treatment’’ column. ‘‘Control’’ indicates animals that
were exposed to bacteria containing empty vector plasmid (no RNAi insert; see Experimental Procedures). A blank entry in the
‘‘RNAi Treatment’’ column (in all tables) indicates that the experiment was done under standard (non-RNAi) conditions.
muEx353 and muEx354 represent independent kri-1::gfp transgenic lines created as described in Experimental Procedures.
a Some observed animals were censored (see Experimental Procedures). The number of independent trials is in parentheses.
b Indicates experiments depicted in Figure 1.
c Indicates experiments depicted in Figure 2.
d p value versus nontransgenic siblings.kri-1 Is Required for DAF-16 Nuclear Localization
in Animals Lacking a Germline
The intestine appears to be the primary site of daf-16/
FOXO regulation and activity in response to germ-cell
loss. Germ-cell removal causes the nuclear localization
of DAF-16 in the intestine, and DAF-16 activity in the intes-
tine is sufficient to account for the entire life-span exten-
sion produced by germline ablation (Libina et al., 2003;
Lin et al., 2001). To ask whether kri-1 was important for in-
testinal DAF-16 nuclear localization, we used RNAi to
knock down kri-1 function in a daf-16;glp-1 double mutant
carrying a rescuing DAF-16::GFP fusion (Table S1). On day
1 of adulthood, 65% of control animals without a germline
displayed DAF-16 nuclear localization in a majority of their
intestinal cells. In contrast, only 5% of animals treated with
kri-1 RNAi displayed this localization (Figures 3A–3C; Ta-
ble 2). This finding suggests that kri-1 promotes longevity
when germ cells are absent by mediating or facilitating
the nuclear localization of DAF-16 in the intestine.
The DAF-9/DAF-12 Lipophilic-Hormone Signaling
Pathway Is Also Required for DAF-16 Nuclear
Localization in the Intestine
Mutations in the lipophilic-hormone signaling genes daf-
12/NHR and daf-9/P450 also prevent the life-extending
effect of germline ablation. In principle, these genes could
act in parallel to daf-16, or they could act downstream of
daf-16 to transmit the effects of DAF-16 activity in intesti-
nal cells to other tissues of the body. Alternatively, they
could be part of an upstream signaling system that some-
how senses the absence of the germline and, in response,
localizes DAF-16 to intestinal nuclei. To investigate this,
we asked whether daf-12 and daf-9 were required for
DAF-16 nuclear localization in animals without a germline.
We found that they were: Reducing daf-12 or daf-9 func-Ction with RNAi caused a reduction in DAF-16 nuclear local-
ization in germline-deficient animals (Figures 3A, 3D, and
3E; Table 2). On day 1 of adulthood, only 29% of daf-12
RNAi-treated and 26% of daf-9 RNAi-treated animals ex-
hibited DAF-16 nuclear localization in the intestine, com-
pared to 65% of control animals. Similar effects were
seen in daf-12 or daf-9 mutant animals (Table S2). These
findings suggest that the germline utilizes lipophilic-
hormone signaling to regulate DAF-16 activity in the intes-
tine. One simple model is that in animals without a germ-
line, a lipophilic hormone is produced by DAF-9; received
by DAF-12; and, in association with KRI-1, triggers DAF-16
nuclear localization in the intestine. The fact that we
observed residual DAF-16 nuclear localization in both
mutants suggests, however, thatdaf-12 anddaf-9 function
may be partially redundant with other factors.
DAF-18/PTEN Phosphatase Activity Is Required for
the Longevity of Animals that Lack a Germline
daf-18 encodes a PTEN phosphatase that antagonizes
AGE-1/PI 3-kinase signaling downstream of DAF-2 (Gil
et al., 1999; Ogg and Ruvkun, 1998). Both the increased
longevity of daf-2 mutants and the nuclear localization of
DAF-16 in daf-2 mutants is daf-18 dependent (Dorman
et al., 1995; Larsen et al., 1995; Lin et al., 2001). Since
DAF-16 nuclear localization is also regulated by the germ-
line, we wondered whether DAF-18 might function in this
pathway as well. To test this, we assayed the effects of
daf-18 RNAi on the longevity of glp-1 mutants. We found
that daf-18(RNAi);glp-1 animals were not long lived (Table
S1). In addition, we found thatdaf-18RNAi sharply reduced
DAF-16 nuclear localization in animals without a germline
(Figures 3A and 3F; Table 2). It is therefore possible that
germ cells signal through daf-18 to control DAF-16 locali-
zation. Alternatively, daf-18 could act independently ofell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1059
Figure 2. A Full-Length kri-1 cDNA Fusion Is Expressed in the Intestine and Pharynx and Extends the Life Span of kri-1;glp-1
Mutants
Wild-type (A–C) or kri-1(ok1251);glp-1(e2141ts) (D) mutant animals were injected with a kri-1 cDNA::gfp fusion expressed under a kri-1 promoter
sequence (Pkri-1::gfp::kri-1; see Experimental Procedures).
(A) Pkri-1::gfp::kri-1 is expressed in the intestine (int) and pharynx (ph) of a late L1 larvae. Expression can be seen in these tissues throughout life (data
not shown).
(B and C) Adult intestinal expression, including apical (ap) localization in some cells (B). Nuclear enrichment of the fusion protein (n) is observed in
some cells (C).
(D) Life-span analysis of kri-1(ok1251);glp-1(e2141ts) animals expressingPkri-1::gfp::kri-1. In this and subsequent figures, each transgene is indicated
by a Kenyon lab allele number, except that the prefix mu is omitted. Ex, extrachromosomal array; Is, integrated array. muEx354 and muEx353 are
independent transgenic lines described in the Table 1 legend. kri-1;glp-1-S represents the nontransgenic siblings of muEx354 (a) or muEx353 (b)
selected under the fluorescent dissecting microscope in parallel with transgenic animals. Life-span data details for the curves found in (D) are indi-
cated in Table 1 by c. (A) and (B) are at 400magnification; (C) is at 250magnification. Pkri-1::gfp::kri-1 expression could also rescue the small and
pale appearance of kri-1 mutant animals (data not shown).the germline pathway. For instance, removing DAF-18
could upregulate the DAF-2/insulin/IGF-1 pathway, result-
ing in high levels of DAF-16 phosphorylation and nuclear
exclusion irrespective of the state of the germline.
kri-1, daf-12, and daf-9 Are Not Required for DAF-16
Nuclear Localization in Insulin/IGF-1-Pathway
Mutants
Loss of DAF-2 receptor activity promotes DAF-16 nuclear
localization in many tissue types, including the intestine
(Henderson and Johnson, 2001; Lin et al., 2001). Therefore
we wondered whether kri-1, daf-12, and daf-9 might
also be required for DAF-16 nuclear localization in daf-2
mutants. We assayed intestinal DAF-16 nuclear localiza-
tion in daf-2(RNAi) animals that had an intact germline.
As expected, daf-18 RNAi strongly reduced DAF-16 nu-
clear localization (Figures 4A–4C; Table 2). However, kri-1,
daf-12, and daf-9 RNAi had only a mild effect (Figures 4A1060 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc.and 4D–4F; Table 2). Thus, unlike daf-18, the role of kri-1,
daf-12, anddaf-9 in promoting DAF-16 nuclear localization
appears to be largely specific to the reproductive pathway.
daf-16 Mutations that Cause Constitutive Nuclear
Localization Bypass the Need for kri-1 and daf-9
but Not daf-12 Function
Animals without a germline live long only when kri-1,daf-12,
and daf-9 are functional, and DAF-16 nuclear localization is
influenced by these same genes. We reasoned that if the
only role of these genes was to promote DAF-16 nuclear lo-
calization, then placing DAF-16 constitutively in the nucleus
should bypass their role in the germline longevity path-
way. To test this, we asked whether a constitutively nuclear
DAF-16 protein, in which the DAF-16 consensus AKT-phos-
phorylation sites were substituted with alanines (named
DAF-16AM::GFP; Lin et al., 2001), would bypass the
need for these genes in promoting the longevity of
Figure 3. Inhibiting kri-1, daf-12, daf-9, or daf-18 Function Reduces DAF-16 Nuclear Localization in the Intestinal Cells of Animals
that Lack a Germline
All animals in this figure are sterile glp-1 mutants.
(A) Percent of germline-deficient animals with DAF-16 intestinal nuclear localization under various RNAi conditions. Graphs represent multiple trials,
except for daf-9, which was later repeated and confirmed using the daf-9(rh50) mutation (see Table S2). Error bars indicate standard error for pro-
portions. See Table 2 for all quantitative data for this graph. ‘‘Control’’ animals are the progeny of adults injected with water (no dsRNA). Additional
negative controls performed using dsRNA for genes with no known effect on longevity (ncl-1 and pcp-1) were indistinguishable from water-injected
controls (p = 0.57 and p = 0.19, respectively; see Table 2). Age-matched untreated animals with germ cells display diffuse DAF-16 expression in
intestinal cells (data not shown). RNAi of kri-1, daf-12, daf-9, and daf-18 significantly reduced the number of germline-deficient animals with intestinal
DAF-16 nuclear localization (p < 0.0001 versus control for all except daf-9, for which p = 0.0019; see Table 2).
(B–F) Images of intestinal cells from germline-deficient animals exposed to dsRNA treatment. Each panel contains a representative picture of either
a control animal (B) displaying DAF-16 nuclear localization or a kri-1 (C), daf-12 (D), daf-9 (E), or daf-18 (F) dsRNA-treated animal displaying diffuse
DAF-16 expression. Images were taken at 630 magnification.germline-deficient animals. This protein has previously
been shown to localize to the nucleus in wild-type animals
and to extend life span to 60% of daf-2() control levels
in a daf-16();daf-2() background.
First, we asked whether constitutively nuclear DAF-16
could rescue the short life span of daf-16;glp-1 animals.
In multiple trials, we found that DAF-16AM::GFP extendsCthe life span of daf-16;glp-1 mutant animals, though not
to the extent of the endogenous daf-16(+) gene (64%–
76% of glp-1 control levels; Figure 5A; Table S3). Next
we asked whether this increased longevity was dependent
on kri-1, daf-12, and daf-9 gene function. To do this, we
crossed the kri-1(ok1251), daf-12(rh61rh411), or daf-
9(rh50) mutations into daf-16;glp-1 worms carryingell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1061
Table 2. Effect of Gene Knockdown on DAF-16 Intestinal Nuclear Localization
Strain/Conditions
Germ
Cells
Present
dsRNA
Injected
% of Animals
with DAF-16 Nuclear
Localized
Standard
Error
% of
Control
Number of
Animals
(Trials) p Value
Animals with No Germ Cells
daf-16(mu86);glp-1(e2141ts);
muIs109 [Pdaf-16::gfp::daf-16]
no control (water injected) 64.6 3.6 181 (3)
no kri-1 5.26 1.9 8.1 133 (3) <0.0001
no daf-12 29.3 3.6 45 164 (3) <0.0001
no daf-9 25.9 8.4 40 27 (1) 0.0019
no daf-18 15.9 3.0 25 145 (3) <0.0001
no ncl-1 (negative control) 76.0 8.5 117 25 (1) 0.57
no pcp-1 (negative control) 67.3 6.7 104 49 (1) 0.19
daf-2(RNAi) Animals with Germ Cells
daf-16(mu86);daf-2(RNAi)
glp-1(e2141ts);muIs109
[Pdaf-16::gfp::daf-16]
yes control (water injected) 93.9 4.2 33 (2)
yes kri-1 71.9 8.0 77 32 (2) 0.023
yes daf-12 69.7 8.0 74 33 (2) 0.023
yes daf-9 78.6 11 84 14 (1) 0.081
yes daf-18 32.3 8.4 34 31 (2) <0.0001
yes ncl-1 (negative control) 100 0 107 24 (1) 
yes pcp-1 (negative control) 83.3 11 89 12 (1) 1.0
‘‘Germ Cells Present’’ indicates whether animals were raised at the nonpermissive temperature (resulting in no germ cells due to the
temperature-sensitive glp-1mutation) or at the permissive temperature (resulting in a full germline). Assays were conducted at 20ºC
on day 1 of adulthood. Parents of the animals used in this assay were injected with 1 mg/ml of dsRNA for the gene indicated in
‘‘dsRNA Injected.’’ Water-injected controls were injected with pure water (no dsRNA). An animal was scored as having nuclear-
localized DAF-16 if the majority of intestinal cells displayed a nuclear concentration of GFP as assayed with a fluorescent dissecting
microscope. The standard error for proportions was determined. Animals used in the daf-2(RNAi) assay were the siblings of animals
used in the germline-absent nuclear-localization assay. In other words, these worms came from the same dsRNA-injected parents
but were raised differently (on daf-2 RNAi plates at the permissive temperature as opposed to on standard OP50 plates at the non-
permissive temperature; see Experimental Procedures for details).DAF-16AM::GFP. We found that, in the presence of DAF-
16AM::GFP, kri-1 loss of function did not affect the longev-
ity of animals lacking a germline (Figure 5B; Table S3). This
indicates that kri-1 function is dispensable when DAF-16 is
unphosphorylated on these consensus sites and in the nu-
cleus. On the contrary, the daf-12 null mutation strongly
suppressed the longevity of the daf-16;glp-1;DAF-
16AM::GFP animals (Figure 5C; Table S3). This shows that
daf-12 has a function (or functions) in this pathway that
cannot be bypassed by nuclear localization of DAF-16.
Since DAF-9 is predicted to make or modify a ligand for
the DAF-12 receptor, we expected daf-9 mutations to be-
have similarly to daf-12 mutations in this assay. Surpris-
ingly, in 2 out of 3 trials, the daf-9(rh50) allele had no effect
on the longevity of daf-16;glp-1 animals carrying DAF-
16AM::GFP (Figure 5D; Table S3). While not a null mutation,
this same daf-9 allele completely blocks the longevity of
animals lacking a germline (Gerisch et al., 2001). We there-
fore conclude that a constitutively nuclear DAF-16 protein
can bypass the need for kri-1 and daf-9, but not daf-12, in1062 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Incthe germline longevity pathway. These findings suggest
that the primary requirement of kri-1 and daf-9 in the germ-
line signaling pathway is to effect the nuclear localization of
DAF-16, whereas daf-12 has a second essential role in
promoting longevity.
DISCUSSION
The mechanism by which different tissues interact with
one another to coordinate the aging process is not well un-
derstood. In C. elegans, cells within the reproductive sys-
tem influence aging since removing the germ cells extends
life span. In nature, this process may provide the animal
with a means of slowing its aging process if germline
maturation or proliferation is somehow delayed, thereby
coordinating the rate of aging with reproduction. At the
molecular level, the life-span extension caused by germ-
line removal appears to be initiated by signaling from the
reproductive system to the intestine since DAF-16 accu-
mulates in intestinal nuclei and functions in the intestine.
Figure 4. Inhibiting kri-1, daf-12, or daf-9 Function Only Slightly Reduces DAF-16 Nuclear Localization in the Intestinal Cells of daf-
2(RNAi) Animals
All animals in this assay have germ cells.
(A) Percent of daf-2(RNAi) animals with DAF-16 intestinal nuclear localization under various RNAi conditions. See Table 2 for all quantitative data for
this graph. Error-bar determination, controls, and trials are presented as in Figure 3. Additional controls raised on ncl-1 RNAi plates showed minimal
DAF-16 nuclear localization (data not shown). Compared to daf-18 RNAi conditions (p < 0.0001 versus control), daf-2(RNAi) animals exposed to kri-1,
daf-12, or daf-9 dsRNA showed minor or no decrease in DAF-16 nuclear localization (p = 0.023, p = 0.023, and p = 0.08, respectively; see Table 2).
(B–F) Representative images of intestinal cells of daf-2(RNAi) animals exposed to control conditions (B) or to dsRNA for daf-18 (C), kri-1 (D), daf-12 (E),
or daf-9 (F). Images were taken at 630 magnification.to increase life span when the germline is removed. Our
findings suggest that the germline communicates with
the intestine via lipophilic-hormone signaling and that the
response to this signaling in the intestine requires the pro-
tein KRI-1.
kri-1 Is Required for the Extended Longevity
of Animals without a Germline
Through an RNAi-based suppressor screen, we identified
kri-1 as a gene required for the longevity of animals lack-ing a germline. In the absence of kri-1, germline removal
does not extend life span. With any life-span-shortening
treatment, one has to be concerned about the health of
the animals. However, kri-1 RNAi does not shorten wild-
type life span. In addition, loss of kri-1 lengthens the life
spans of daf-2(e1370) mutants by up to20%. This would
not be expected if loss of kri-1 impaired the health of the
animal. We also found that overexpression of kri-1 could
extend the life span of wild-type animals by 19% in 1 of 2
trials (control mean 18.0 days, muEx344 kri-1::gfp meanCell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1063
Figure 5. Constitutively Nuclear DAF-16 Can Bypass the Need for kri-1 and daf-9, but Not daf-12, in the Germline Pathway
These panels show representative life-span assays for germline-deficient animals expressing a functional daf-16AM::gfp transgene (named muEx158)
in kri-1(ok1251), daf-12(rh61rh411), or daf-9(rh50) mutant backgrounds. All strains carry daf-16(mu86) (except glp-1 in [A]) and glp-1(e2141ts) muta-
tions, and all animals lack germ cells. See Table S3 for all life-span data, additional trials, and statistics. Trials shown in this figure are indicated by *
in Table S3.
(A) daf-16AM::gfp can rescue the longevity defect of daf-16(mu86);glp-1(e2141ts) animals to 64%–76% of control levels. daf-16;glp-1–S (and analo-
gous animals in [B]–[D]) represents the nontransgenic siblings of muEx158-containing animals selected under the fluorescent dissecting microscope
in parallel with transgenic animals.
(B) kri-1(ok1251) does not shorten the life span of muEx158-expressing animals. Curiously, the kri-1 mutation may even enhance longevity in this con-
text. We do not have an explanation for this. Perhaps it is related to the fact that loss of kri-1 also extends the life span of daf-2(e1370) mutants,
in which DAF-16 is also completely nuclear.
(C) daf-12(rh61rh411) blocks the life-span extension caused by muEx158.
(D) daf-9(rh50) did not significantly shorten the life span of muEx158-expressing animals in 2 out of 3 trials (see Table S3).21.5 days, p < 0.0001). Thus, kri-1 may play an instructive
role in promoting longevity.
The kri-1() mutant phenotype is reminiscent of daf-
12() and daf-9() mutant phenotypes. In each mutant,
germline removal no longer lengthens life span, but wild-
type life span is only mildly affected. In addition, like loss
of kri-1, loss of daf-12 or daf-9 can extend the life span
of the strong daf-2(e1370) mutant but not weaker daf-2
mutants (Gems et al., 1998; Gerisch et al., 2001; Larsen
et al., 1995). This distinctive epistasis pattern links kri-1
to daf-12 and daf-9 and suggests that, in animals lacking
a germline, these three genes may function in a common
pathway that extends life span.
kri-1 Acts on the Receiving End of the Germline-to-
Intestine Signaling Pathway
In principle, kri-1 could act in the reproductive system, the
intestine, or another tissue to influence life span. We found1064 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc.that a rescuing kri-1::gfp fusion driven by the kri-1 pro-
moter was expressed specifically in the intestine and phar-
ynx. This fusion was able to extend the life span of a kri-1
mutant. Given the demonstrated importance of the intes-
tine in this pathway, the simplest interpretation of these
findings is that KRI-1 acts in the intestine to increase life
span.
KRI-1 acts to promote DAF-16 nuclear localization since
DAF-16 nuclear localization is sharply reduced in germ-
line-deficient kri-1() animals. This may be the only func-
tion of KRI-1 in this pathway since the need for KRI-1 is
overcome by DAF-16AM, a mutant DAF-16 protein that lo-
calizes to the nucleus constitutively. DAF-16AM lacks the
four consensus AKT-phosphorylation sites through which
the DAF-2 pathway prevents DAF-16 nuclear accumula-
tion in wild-type animals. Thus, KRI-1 could promote
DAF-16 nuclear localization by preventing the phosphory-
lation of DAF-16 on these sites, or it could do something
that overcomes the effect of this phosphorylation. It is also
possible that removing its AKT-phosphorylation sites not
only localizes DAF-16 to the nucleus but also renders it ac-
tive for transcriptional regulation. In this case, KRI-1 might
be required not simply to localize DAF-16 to the nucleus
but also to put it into an active regulatory state.
The kri-1 gene is predicted to encode two protein iso-
forms, each of which contains a series of ankyrin repeats,
which are protein-protein interaction domains, and
a FERM domain, which mediates interaction of the cyto-
skeleton with proteins at the plasma membrane (Chishti
et al., 1998). KRI-1 may therefore be part of a spatially re-
stricted protein complex whose activity regulates DAF-16.
Consistent with this, animals expressing kri-1::gfp dis-
played enrichment of the protein at the apical and apicolat-
eral sides of some intestinal cells. Some animals also dis-
played an enrichment of KRI-1 in the nuclei of intestinal
cells, a phenotype observed previously with the human
ortholog KRIT-1 in mammalian cell culture (Zawistowski
et al., 2005). Whether KRI-1 could potentially influence
gene expression is unknown.
Because KRI-1 has ankyrin-repeat domains, it is likely to
interact physically with other signaling proteins. Some
possible candidates for these proteins come from studies
of kri-1’s mammalian ortholog KRIT1/CCM1, a human dis-
ease gene involved in cerebral cavernous malformations
(Laberge-le Couteulx et al., 1999; Sahoo et al., 1999).
Mammalian KRIT1 can physically interact with compo-
nents of both integrin (Zawistowski et al., 2002) and p38/
MAP kinase signaling cascades (Zawistowski et al.,
2005). In C. elegans, alterations in integrin signaling can
extend life span, although in a daf-16-independent way
(Hansen et al., 2005). Mutations in p38/MAPK pathway
members suppress the resistance of germline-deficient
animals to infection by pathogenic bacteria (Kim et al.,
2002). It will be interesting to determine whether kri-1
acts through integrin or p38/MAPK pathways to promote
longevity. It is also intriguing that, like kri-1(), activated
RAS can increase the life span of strong daf-2 mutants
(Nanji et al., 2005), suggesting another possible functional
interaction. Finally, since we observed that KRI-1 can be
found in the nucleus, it could physically interact with
DAF-12, a nuclear-localized regulatory protein. However,
KRI-1 cannot be an obligate DAF-12 partner since it is
not required for dauer formation or for the DAF-16-inde-
pendent role that DAF-12 plays in the germline pathway
(discussed below).
Germline Regulation of DAF-16 Localization by
Lipophilic-Hormone Signaling
One of the most important questions about the germline
signaling pathway is how information about the reproduc-
tive system is signaled to the intestine. We have found that,
in daf-12 and daf-9 mutants, DAF-16 nuclear localization
in the intestine is inhibited in germline-deficient animals.
Thus, the reproductive system communicates with the in-
testine, at least in part, via the DAF-9/DAF-12 lipophilic-
hormone pathway. We also find that daf-9 is no longerrequired for life-span extension in the presence of the
nuclear-localized DAF-16AM protein, consistent with the
interpretation that the daf-9-dependent signal acts up-
stream of daf-16. The daf-9/daf-12 pathway could influ-
ence DAF-16 activity as well as its localization since
mutations in these genes completely prevent life-span ex-
tension but partially inhibit DAF-16 nuclear localization.
How germ-cell ablation activates lipophilic-hormone
signaling is not clear. daf-9 is expressed in the somatic go-
nad, the nervous system, and the hypodermis, but not in
the intestine (Mak and Ruvkun, 2004). The pattern of daf-9
expression is not changed in response to germline ablation
(S. Behrman and C.K., unpublished data), suggesting that
regulation may be exerted at the level of substrate availabil-
ity rather than DAF-9 abundance or localization. DAF-9 is
thought to modify cholesterol or a cholesterol derivative,
so one possibility is that the level of available substrate rises
when the germline is removed.
Once produced, the daf-9-dependent hormone pre-
sumably binds to and activates the nuclear receptor
DAF-12. How might DAF-12 influence DAF-16 localiza-
tion? DAF-12 is constitutively localized in nuclei through-
out the animal, including the intestine (Antebi et al.,
2000), and DAF-12 has been reported to bind to DAF-16
in vitro (Dowell et al., 2003). If DAF-16 and DAF-12 interact
physically inC. elegans, then ligand bound DAF-12 may in-
crease the level of DAF-16 in the nucleus by binding DAF-16
in the nucleus and preventing its export. DAF-16 (Hender-
son and Johnson, 2001; Lee et al., 2001; Lin et al., 2001)
and DAF-12 are both expressed throughout the animal;
however, DAF-16 nuclear localization does not occur in all
tissues when the germline is removed (Lin et al., 2001). Per-
haps this tissue specificity is provided by KRI-1, which has
a much more restricted expression pattern.
Unlike kri-1 and daf-9 function, daf-12 function cannot
be bypassed by DAF-16AM. Thus, in addition to promoting
DAF-16 nuclear localization, DAF-12 must play an addi-
tional role that is independent of DAF-9 activity. Consistent
with this, removing daf-12 (but not kri-1 or daf-9) in daf-
16() mutants that lack germ cells further shortens life
span (Table S3). This would not be expected if all daf-12
functions were dependent on daf-16. Perhaps DAF-12
acts in part in parallel to DAF-16 to regulate downstream
longevity genes.
A Tissue-Specific Branch of the DAF-16
Longevity Network
As with loss of germ cells, the life-span extension caused
by daf-2mutation is associated with DAF-16 nuclear local-
ization and requires DAF-16 activity. However, kri-1,daf-12,
and daf-9 are not required for DAF-16 localization or DAF-16
function in daf-2 mutants. Thus, the life-span-extending
functions of kri-1,daf-12, and daf-9 are restricted to the re-
productive pathway. A simple model is that KRI-1, DAF-
12, and DAF-9 activities are recruited to activate DAF-16
when germ cells are missing, but not when insulin/IGF-1
signaling is reduced. In this way, the germline pathwayCell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc. 1065
can be considered a tissue-specific conduit to more gen-
eral life-span machinery.
As described above, DAF-12 has a life-span-extending
function that is independent of its role in DAF-16 nuclear
localization. This finding provides a possible explanation
for the observation that, in daf-2(e1370) mutants, in which
DAF-16 is transcriptionally active and highly concentrated
in nuclei throughout the animal, germline ablation pro-
duces a further doubling of life span (Hsin and Kenyon,
1999). Perhaps loss of the germline extends the life span
of daf-2(e1370) mutants because it induces the life-span-
extending activities of DAF-12.
Conclusions
In summary, our findings provide new insight into the
mechanism by which the reproductive system can affect
an animal’s rate of aging. The reproductive systems of flies
and mammals also appear to influence life span, although
the underlying mechanisms have not been explored. Flies
carrying a mutation that blocks oogenesis display delayed
mortality, and old mice whose ovaries have been replaced
with those of younger mice have an increased life expec-
tancy (Cargill et al., 2003; Sgro and Partridge, 1999). Each
longevity gene described in our study has an ortholog in
mammals. Given the remarkably high degree of evolution-
ary conservation of the insulin/IGF-1 longevity pathway
(Tatar et al., 2003), understanding this branch of the
DAF-16/FOXO regulatory network may lead to an under-
standing of how reproductive status affects aging in higher
organisms as well.
EXPERIMENTAL PROCEDURES
RNA Interference and Screening
RNAi by feeding was generally performed as described (Kamath et al.,
2001). Briefly, RNAi clones were inoculated overnight at 37ºC in LB plus
tetracycline at 10 mg/ml and carbenicillin at 100 mg/ml and were then
seeded onto NG-carbenicillin plates. Lawns were induced with 80–
100 ml of 0.1 M IPTG plus 200 mg/ml carbenicillin. For all feeding assays,
worms were exposed to RNAi bacteria from hatching. RNAi by injection
was performed as described (Fire et al., 1998) by injecting gonads with
dsRNA (see Molecular Biology) at a concentration of 1 mg/ml. Injected
worms recovered overnight at 15ºC and were then shifted to 20ºC to lay
eggs for assay use.
For the glp-1 suppressor screen, RNAi clones from the chromosome
I library were inoculated as described above in 96-well format, then
seeded onto individual NG-carbenicillin plates and induced. Fifty to
one hundred glp-1(e2141ts) eggs were seeded per plate and raised
at 25ºC (to eliminate germ cells) for 40 hr, then shifted to 20ºC for
the rest of life. Positive control plates (containing daf-16 RNAi
[pAD43; Dillin et al., 2002] or daf-12 RNAi [pJR3; see below]), were
placed throughout the incubator to determine an appropriate suppres-
sor screening date. The negative control used in the screen and in all
RNAi feeding assays was an empty RNAi vector (pAD12; Dillin et al.,
2002). On day 22 of adulthood, plates with fewer than 5% of animals
still alive were identified (negative control plates had roughly 50% of
animals alive at this time point). Contaminated plates, starved plates,
or plates with outwardly defective or arrested animals were discarded.
All positive hits from the screen were retested using standard life-span
assays of both glp-1 and N2 animals (Table 1 and data not shown). All
clones retrieved from the RNAi library for use were confirmed by se-1066 Cell 124, 1055–1068, March 10, 2006 ª2006 Elsevier Inc.quencing, and the presence of the RNAi insert was typically checked
by PCR prior to an assay.
Molecular Biology and Sequencing
A daf-12 RNAi clone (pJR3) was constructed by inserting 2 kb of daf-
12A1 cDNA sequence at the XhoI and KpnI sites of pAD12, a vector
with bidirectional T7 promoters for dsRNA production (Dillin et al.,
2002). To synthesize dsRNA for injection, template was amplified
from L4440- (RNAi library) or pAD12-based feeding constructs using
modified T7 primers. In vitro transcription was performed using the
T7-based RiboMAX Large Scale RNA Production System (Promega),
and products were checked by electrophoresis for correct size. Prod-
ucts were annealed (68ºC for 15 min, 65ºC for 5 min, 65ºC  5ºC per
cycle for 8 cycles, 4ºC hold) to create dsRNA.
To generate the Pkri-1::gfp::kri-1 (pJR32) construct, an AscI/BamHI
mec-7 promoter fragment was removed from the L3691/pPD117.01
N-terminal GFP vector (a generous gift from Andrew Fire) to generate
plasmid pJR7. A full length kri-1a cDNA (2190 bp) fragment (GenBank
accession number DQ372920) was inserted downstream of and in
frame with gfp at the NheI site of pJR7, and 1.5 kb of kri-1 50 regulatory
sequence was inserted at the ClaI and XmaI sites. All critical regions
were fully sequenced, including the entire cDNA.
Sequence analysis revealed that the kri-1(ok1251) mutation repre-
sents a deletion and complex rearrangement of gene sequence as fol-
lows: at base pair position 1511, there is an insertion of sequence
4015–4304, followed by an insertion of sequence 2956–2975, then an
insertion of sequence AT before resuming sequence at base pair
3115 (all positions are numbered according to the kri-1a unspliced tran-
script sequence from Wormbase, http://www.wormbase.org). These
changes result in the elimination of 1292 bp of gene sequence and
the introduction of a stop codon 16 amino acids downstream of the first
breakpoint, which is upstream of the predicted ankyrin repeats. We
therefore believe this mutation represents a kri-1 null allele.
Transgenic Animals
To generate kri-1::gfp-expressing animals, Pkri-1::gfp::kri-1 (pJR32)
was injected as described (Mello and Fire, 1995) at 50 ng/ml into N2
or kri-1(ok1251);glp-1(e2141ts) animals to generate independent trans-
genic lines (indicated by muEx designation). The coinjection marker
Podr-1::rfp was injected at 100 ng/ml in all cases. The Podr-1::rfp
marker has no effect on life span (Libina et al., 2003). muEx344 was es-
tablished in N2 worms (strain CF2282), while muEx353 and muEx354
were established in a kri-1(ok1251);glp-1(e2141ts) background (strains
CF2310 and CF2311, respectively).
Strain Construction
Strains were maintained as described (Brenner, 1974). kri-1(ok1251)
was generated by the C. elegans Gene Knockout Consortium. We out-
crossed this strain three times to our laboratory N2 stock (N2A) to cre-
ate strain CF2052. These animals display a slight developmental delay
compared to wild-type or kri-1 RNAi-treated animals. The transgenic
arrays muEx158 (daf-16AM::gfp plus coinjection marker sur-5::gfp)
(Lin et al., 2001) and muEx248 (Pdaf-16::gfp::daf-16 plus coinjection
marker Podr-1::rfp) (Libina et al., 2003) were described previously.
muEx248was integrated byg irradiation, followed by outcrossing three
times to daf-16(mu86), to generate muIs109 (a generous gift from Mal-
ene Hansen), which was later mapped to chromosome X. The following
strains were generated using standard genetic procedures: glp-
1(e2141ts)III (outcrossed three times to our N2) (CF1903), daf-
16(mu86)I;glp-1(e2141ts)III (CF1880), kri-1(ok1251)I;glp-1(e2141ts)III
(CF2065), daf-16(mu86)I;glp-1(e2141ts)III;muIs109X (CF1935), daf-16
(mu86)I;glp-1(e2141ts)III;muEx158 (CF2061), daf-16(mu86) kri-1
(ok1251)I;glp-1(e2141ts)III;muEx158 (CF2265), daf-16(mu86)I;glp-1
(e2141ts)III;daf-12(rh61rh411)X;muEx158 (CF2248), daf-16(mu86)I;
glp-1(e2141ts)III;daf-9(rh50)X;muEx158 (CF2263), rrf-3(pk1426)II;daf-
2(e1370)III (CF1814), rrf-3(pk1426)II;daf-2(e1368)III (CF1980), daf-
16(mu86)I;glp-1(e2141ts)III;muEx248 (CF2247), daf-16(mu86)I;glp-1
(e2141ts)III;daf-12(rh61rh411)X;muEx248 (CF2278), daf-16(mu86)I;
glp-1(e2141ts)III;daf-9(rh50)X;muEx248 (CF2288), daf-16(mu86) kri-
1(ok1251)I;glp-1(e2141ts)III;muIs109X (CF2135). CF1880, CF1935,
and CF1814 were constructed by Malene Hansen. The presence of
the daf-9(rh50) mutation was confirmed by sequencing. daf-
12(rh61rh411) and daf-16(mu86) are predicted to be null alleles (Antebi
et al., 2000; Lin et al., 1997). Other strains used included glp-1
(e2141ts)III (not outcrossed), daf-2(e1370)III (CF1041), daf-2(e1368)III
(DR1572), and N2.
Life-Span Analysis
Life-span assays were conducted in general as described previously
(Hansen et al., 2005). All assays were performed at 20ºC, and the L4
stage was counted as day 0 of life. For glp-1 life-span assays, animals
were raised at 25ºC to eliminate germ cells, then shifted to 20ºC at L4 for
the rest of the assay. In the case of muEx158- or muIs109-carrying
strains (and controls), eggs were left at 20ºC for 24 hr, shifted to 25ºC
for 24 hr, then returned to 20ºC at L4 to avoid dauer or other larval ar-
rest. In all cases, glp-1 strains used in life-span assays were completely
sterile. Fertile strains were transferred every other day to fresh plates
until progeny production ceased. Animals that crawled off the plate,
exploded, bagged, or became contaminated were censored. Statview
5.0.1 (SAS) software was used to calculate mean life spans and per-
form statistical analyses. p values were determined using log-rank
(Mantel-Cox) statistics.
DAF-16 Nuclear-Localization Assays
Fertile daf-16(mu86);glp-1(e2141ts);muIs109 [Pdaf-16::gfp::daf-16]
animals (muIs109 contains a functional, rescuing daf-16 construct;
see Table S1) were injected with water (control), kri-1, daf-12, daf-9,
daf-18, pcp-1, or ncl-1 dsRNA (at 1 mg/ml) in the gonad syncytium
and allowed to recover at 15ºC. The following day, injected animals
were shifted to 20ºC to lay eggs for several hours on either OP50 plates
(Figure 3) or on daf-2 RNAi or control RNAi plates (Figure 4). In experi-
ments where animals have no germ cells (Figure 3), eggs were shifted
24 hr later (to avoid developmental arrest) to 25ºC, then back to 20ºC at
L4 (roughly 24 hr later). Otherwise, eggs were left at 20ºC for all of de-
velopment to allow for germ-cell proliferation (daf-2(RNAi) experi-
ments; Figure 4). On day 1 of adulthood, these progeny were assayed
for DAF-16 nuclear localization in intestinal cells using a fluorescent
dissecting microscope. Other cell types were not evaluated. Animals
were scored as having nuclear-localized DAF-16 if the majority of intes-
tinal cells displayed a distinct concentration of GFP in the nucleus.
Controls using dsRNA for gfp resulted in GFP knockdown for at least
4 days into the progeny’s adulthood, indicating that gene knockdown
is in effect at the time of the assay (day 1 of adulthood). Similar results
were observed in DAF-16::GFP strains when kri-1(ok1251), daf-
12(rh61rh411), or daf-9(rh50) loss-of-function mutations were intro-
duced (Table S2). Similar results were also observed when assayed us-
ing RNAi by feeding, although transgene expression was sometimes
low under these conditions (data not shown). Similar procedures
were used for nuclear-localization assays in mutant backgrounds. In
general, daf-12 mutation or dsRNA did not affect the overall level of
DAF-16::GFP. In some cases, daf-9 or kri-1 reduction of function re-
sulted in lowered DAF-16::GFP levels, although this did not prevent
scoring of DAF-16 nuclear localization, nor was it quantified. p values
were determined using Stata 8.2 software (StataCorp, College Station,
TX, USA).
Because reducing daf-12 or daf-9 function produced a partial effect
on DAF-16 nuclear localization, we performed a double-blind experi-
ment to eliminate any potential observer bias. We (J.R.B.) numbered
C. elegans culture dishes (no strain identification) containing the strain
daf-16;glp-1;muEx248 [DAF-16::GFP], or the same strain in a daf-12()
or daf-9() background, and gave the plates to an independent naive
observer (T. Yamawaki) to score blind on day 1 of adulthood. The inde-
pendent observer found in the control, 52% (± 6.7%) animals with nu-
clear-localized DAF-16 (n = 56); in daf-12(), 25% (± 10.8%) animalsCwith nuclear-localized DAF-16 (n = 16); and in daf-9(), 0% animals
with nuclear-localized DAF-16 (n = 29). This confirmed our original
observation.
Dauer Assays
rrf-3(pk1426);daf-2(e1368) animals were synchronized as eggs, raised
on RNAi plates at 20ºC, and then allowed to lay eggs for 2 hr onto fresh
RNAi plates. These F1 progeny were shifted to 25.5ºC, and 72 hr later,
the number of dauer, L1/L2 arrested, or adult animals was assayed.
Microscopy
All pictures were captured using a Retiga EXi Fast1394 CCD digital
camera (QImaging, Burnaby, BC, Canada) using a Zeiss Axioplan 2
compound microscope (Zeiss Corporation, Germany). Openlab 4.0.2
software (Improvision, Coventry, UK) was used for image acquisition,
and all image processing was done using Photoshop CS 8.0 (Adobe,
USA). Photos were taken within 10 min of placing the animals on the
slide. Nuclear-localization assays were conducted on either a Zeiss
M2Bio or Leica MZ16F fluorescent dissecting microscope with stan-
dard filter sets.
Supplemental Data
Supplemental Data include four tables and can be found with this arti-
cle online at http://www.cell.com/cgi/content/full/124/5/1055/DC1/.
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